Exanthema subitum - Symptoms, Causes, Treatment & Prevention

```html

Overview

Exanthema subitum, also known as roseola infantum, sixth disease, or “baby rash,” is a common, self‑limited viral infection that typically occurs in infants and young children. The illness is characterized by a sudden high fever that abruptly resolves, followed by a pink‑to‑red maculopapular rash that spreads from the trunk to the limbs.

Who it affects

• Age: Most cases occur between 6 months and 2 years of age, with peak incidence at 9–12 months.
• Sex: Slight male predominance (≈55 % male).
• Geography: Worldwide distribution; more common in temperate climates during late winter‑early spring.

Prevalence

• In the United States, the two most common viruses that cause exanthema subitum—human herpesvirus‑6 (HHV‑6) and human herpesvirus‑7 (HHV‑7)—infect >90 % of children by age 2 years (CDC, 2022).
• Seroprevalence studies from Europe and Asia show similar rates, indicating that most children will have been exposed at least once during early childhood.

Symptoms

The clinical picture evolves in two distinct phases.

Phase 1 – High‑grade fever

• Fever: Rapid onset of temperature ≥ 39 °C (102.2 °F); often peaks at 40 °C (104 °F).
• Duration: 3–5 days, rarely longer than 7 days.
• Associated signs: Irritability, mild cough, runny nose, and decreased appetite. Seizures (febrile) may occur in ~2–5 % of children, especially those with a family history of febrile seizures.

Phase 2 – Rash

• Onset: Appears 12–24 hours after the fever drops.
• Appearance: Small, rose‑pink macules and papules that may coalesce; non‑pruritic (not itchy).
• Distribution: Begins on the trunk and spreads outward to the neck, arms, and legs; face is usually spared.
• Duration: 1–3 days, then fades without leaving marks.

Other possible findings

• Lymphadenopathy (mild cervical or posterior auricular nodes).
• Occasional mild gastro‑intestinal upset (vomiting or diarrhea).
• Rarely, a transient elevation of liver enzymes.

Causes and Risk Factors

Exanthema subitum is caused by primary infection with either human herpesvirus‑6 (HHV‑6) or human herpesvirus‑7 (HHV‑7). Both are DNA viruses of the Herpesviridae family.

Pathogenesis

• Transmission occurs via respiratory secretions (nasal/oral droplets) or saliva. The virus replicates in the nasopharynx and later spreads hematogenously.
• After an incubation period of 5–15 days, the virus reaches the central nervous system, provoking the high fever.
• When the immune response begins to control viral replication, the fever subsides and the characteristic rash appears.

Risk Factors for Primary Infection

• Age: Infants lose maternal antibodies around 6 months, creating a window of susceptibility.
• Day‑care attendance: Close contact with other children increases exposure.
• Older siblings: School‑aged siblings may bring the virus home.
• Immunocompromised status: Reactivation of HHV‑6/7 can cause severe disease, but primary infection in otherwise healthy infants is usually benign.

Diagnosis

Exanthema subitum is primarily a clinical diagnosis; laboratory testing is rarely required.

Clinical assessment

1. History of abrupt high fever followed by a rapid resolution.
2. Typical rash appearance and distribution.
3. Age of the patient (6–24 months).

Laboratory & imaging (optional)

• Serology: Detection of IgM antibodies against HHV‑6/7 confirms recent infection (used mainly in research or atypical cases).
• Polymerase chain reaction (PCR): Viral DNA can be identified in blood, saliva, or CSF; indicated only when complications (e.g., encephalitis) are suspected.
• Complete blood count (CBC): May show mild leukopenia or lymphocytosis; not diagnostic.
• Lumbar puncture: Reserved for children with neurological signs (e.g., seizures, altered mental status) to rule out meningitis.

Differential diagnosis

Other exanthematous illnesses that can mimic roseola include measles, rubella, erythema infectiosum (parvovirus B19), and Kawasaki disease. Key distinguishing features are the timing of fever relative to rash and the rash’s distribution.

Treatment Options

Because exanthema subitum is viral and self‑limited, treatment focuses on symptom relief and supportive care.

Fever management

• Acetaminophen (paracetamol): 15 mg/kg per dose every 4–6 hours, not exceeding 75 mg/kg/day.
• Ibuprofen: 10 mg/kg per dose every 6–8 hours for children >6 months; avoid if the child is dehydrated or has a known kidney issue.
• Physical measures – light clothing, lukewarm sponge baths.

Rash care

• Rash is non‑pruritic; no topical steroids or antihistamines are needed.
• Keep skin clean and dry; use mild soap and lukewarm water.

Hydration & nutrition

• Offer frequent small feeds; breast‑fed infants should continue to nurse.
• Oral rehydration solutions (ORS) if vomiting or poor intake persists.

When antivirals are considered

Antiviral therapy (e.g., ganciclovir or foscarnet) is reserved for severe HHV‑6/7 disease in immunocompromised patients (organ transplant, hematologic malignancy). Routine use in healthy infants is not recommended.

Monitoring for seizures

• Febrile seizures are usually brief and do not require long‑term anticonvulsants.
• If a seizure occurs, ensure airway protection, position the child safely, and seek urgent medical evaluation.

Living with Exanthema Subitum

Although the illness resolves within a week, parents often worry about comfort and preventing spread.

Daily management tips

• Fever tracking: Record temperature every 4 hours; seek care if > 40 °C (104 °F) persists > 24 hours.
• Comfort measures: Light clothing, fans for air circulation, and gentle soothing (e.g., rocking, soft music).
• Hydration: Breast milk, formula, or clear fluids; avoid sugary drinks.
• Hygiene: Wash hands frequently; disinfect toys and surfaces daily.
• Attending day‑care: Most pediatricians advise keeping the child at home until the fever has been afebrile for 24 hours and the rash has faded.
• Vaccination schedule: Exanthema subitum does not interfere with routine immunizations; maintain the standard schedule.

Emotional support

Parents may feel anxious because the fever can be high. Reassure them that:

• The fever usually drops spontaneously.
• Complications are rare in healthy kids.
• Early medical contact is essential only for warning signs (see below).

Prevention

Since the virus spreads by respiratory droplets, complete prevention is difficult, but risk can be reduced.

• Hand hygiene: Wash hands with soap and water for at least 20 seconds after diaper changes, coughing, or sneezing.
• Avoid sharing utensils: Use separate bottles, sippy cups, and pacifiers for each child.
• Limit exposure during outbreaks: If a sibling is diagnosed with roseola, keep the infant’s contact brief until the fever resolves.
• Maintain indoor air quality: Use a humidifier in dry winter months to keep mucosal membranes moist.
• Vaccination: No vaccine exists for HHV‑6/7, but staying up to date on other vaccines (e.g., measles, varicella) prevents confusion with other exanthems.

Complications

Complications are uncommon in immunocompetent children, but they can occur, especially with high fevers or in vulnerable populations.

• Febrile seizures: Occur in 2–5 % of cases; usually simple, generalized, and do not cause long‑term damage.
• Encephalitis: Very rare (<0.1 %); presents with altered consciousness, focal neurological deficits, or prolonged seizures.
• Myocarditis and hepatitis: Documented in isolated case reports, mainly in immunocompromised hosts.
• Reactivation in transplant or AIDS patients: Can lead to graft‑versus‑host disease‑like illness or severe systemic infection.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention (CDC). “Human Herpesvirus 6 (HHV‑6) and 7 (HHV‑7).” Updated 2022. https://www.cdc.gov
• Mayo Clinic. “Roseola (Sixth Disease).” Reviewed 2023. https://www.mayoclinic.org
• National Institutes of Health (NIH). “HHV‑6 Infection.” MedlinePlus, 2023. https://medlineplus.gov
• Cleveland Clinic. “Roseola (Exanthema Subitum) Causes, Symptoms, and Treatment.” 2024. https://my.clevelandclinic.org
• World Health Organization (WHO). “Herpesviridae: HHV‑6 and HHV‑7.” 2022. https://www.who.int

```